ZAGAMI, PAOLA

ZAGAMI, PAOLA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer 2025 Zagami, PaolaBerton Giachetti, Pier Paolo MariaCurigliano, GiuseppeCriscitiello, Carmen + Article (author) -
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment 2024 Corso G.Fusco N.Guerini-Rocco E.Criscitiello C.Zagami P.La Vecchia C.Tarantino P.Bianchi B.Massari G.Polizzi A.Curigliano G.Nicosia L.Sacchini V.Veronesi P. + Article (author) -
Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing? 2024 P. ZagamiG. Curigliano + Article (author) -
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 2024 Boscolo Bielo L.Guerini Rocco E.Trapani D.Zagami P.Crimini E.Venetis K.Fusco N.Criscitiello C.Curigliano G. + Article (author) -
UNDERSTANDING METASTASIS MIXED - TREATMENT RESPONSES THROUGH GENOMIC ANALYSES. 2024 ZAGAMI, PAOLA Doctoral Thesis -
Cardiotoxicity of Agents Used in Patients With Breast Cancer 2024 Zagami, PaolaTrapani, DarioCorti, ChiaraValenza, CarmineCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure 2023 Antonarelli, GCorti, CTarantino, PZagami, PMarra, ATrapani, DCurigliano, G + Article (author) -
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 2023 P. ZagamiG. AntonarelliG. CuriglianoF. Conforti + Article (author) -
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 2023 Morganti, StefaniaMarra, AntonioAscione, LilianaVenetis, KonstantinosSajjadi, ElhamZagami, PaolaGiugliano, FedericaBerton Giachetti, Pier Paolo MariaDe Camilli, ElisaCurigliano, GiuseppeFusco, NicolaCriscitiello, Carmen + Article (author) -
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 2023 Zattarin, EmmaMariani, LuigiLeporati, RitaProvenzano, LeonardoLigorio, FrancescaLobefaro, RiccardoVingiani, AndreaNichetti, FedericoBernocchi, OttaviaMarra, AntonioZagami, PaolaSposetti, CaterinaLosurdo, AgneseGenerali, DanieleCurigliano, GiuseppePruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Metaplastic breast cancer: an all-round multidisciplinary consensus 2023 Corso, GiovanniCriscitiello, CarmenNicosia, LucaPesapane, FilippoCalvello, MariarosariaZagami, PaolaPorta, Francesca MariaLa Vecchia, CarloVeronesi, PaoloFusco, Nicola + Article (author) -
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases 2023 Trillo, PamelaTrapani, DarioZagami, PaolaGiugliano, FedericaVivanet, GraziaAscione, LilianaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 2023 Sposetti, CaterinaCorti, ChiaraProvenzano, LeonardoVingiani, AndreaZagami, PaolaBoldrini, LauraSchianca, Ambra CarnevaleCriscitiello, CarmenCurigliano, GiuseppePruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 2023 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
HER2-positive breast cancer: cotargeting to overcome treatment resistance 2023 Zagami P.Curigliano G. + Article (author) -
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative 2022 Ascione, LilianaZagami, PaolaCrimini, EdoardoCurigliano, GiuseppeCriscitiello, Carmen + Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 2022 Morganti, SMarra, AVenetis, KSajjadi, EAscione, LCorti, CZagami, PZattoni, LCurigliano, GFusco, NCriscitiello, C + Article (author) -
Triple negative breast cancer: Pitfalls and progress 2022 Zagami P. + Article (author) -
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial 2022 Conforti, FabioDella Vigna, PaoloPerrino, MatteoZagami, PaolaCorti, ChiaraGuerini-Rocco, ElenaDe Vincenzo, Fabio + Article (author) -